ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,639Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 2343

$1.06M Total Retail Price of All Prescriptions

Rank: 95 out of 2343

634 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 17,162 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 954 807 1 1
AMLODIPINE BESYLATE 772 651 2 5
LEVOTHYROXINE SODIUM 714 614 3 2
METFORMIN HCL 589 419 4 9
FUROSEMIDE 537 504 5 6
ATENOLOL 528 430 6 12
OMEPRAZOLE 511 396 7 4
LISINOPRIL 501 421 8 3
METOPROLOL TARTRATE 444 345 9 7
QUINAPRIL HCL 428 336 10 73
SERTRALINE HCL 370 317 11 20
POTASSIUM CHLORIDE 326 297 12 18
DONEPEZIL HCL 322 311 13 21
HYDROCODONE-ACETAMINOPHEN 305 211 S3 14 13
NEXIUM 303 226 15 33
ADVAIR DISKUS 269 235 16 34
CLOPIDOGREL 267 245 17 26
GLYBURIDE 260 211 R 18 62
TRAMADOL HCL 248 216 19 25
NABUMETONE 247 192 20 259
DIOVAN 217 157 21 23
ALENDRONATE SODIUM 216 199 22 28
GLIMEPIRIDE 203 152 23 45
HYDROCHLOROTHIAZIDE 198 184 24 11
PLAVIX 193 182 25 38
WARFARIN SODIUM 183 182 26 8
DIGOXIN 182 158 27 35
ATORVASTATIN CALCIUM 168 125 28 10
METOPROLOL SUCCINATE 168 137 28 14
ALLOPURINOL 167 152 30 31
DICLOFENAC SODIUM 165 142 31 155
ISOSORBIDE MONONITRATE ER 162 149 32 32
SPIRIVA 158 107 33 48
GABAPENTIN 157 128 34 16
CRESTOR 157 109 34 30
LOVASTATIN 155 121 36 47
TRIAMTERENE-HCTZ 155 150 36 57
NITROGLYCERIN PATCH 153 153 38 147
CARVEDILOL 152 134 39 27
POLYETHYLENE GLYCOL 3350 148 141 40 54
NAMENDA 140 140 41 36
PANTOPRAZOLE SODIUM 135 90 42 22
PRAVASTATIN SODIUM 130 104 43 15
FENTANYL 126 101 S2 44 69
CARBIDOPA-LEVODOPA 125 106 45 85
ZOLPIDEM TARTRATE 121 89 46 24
CELEBREX 116 100 47 71
KLOR-CON M20 116 81 47 44
PROAIR HFA 116 85 47 86
TRIAMTERENE-HYDROCHLOROTHIAZID 115 100 50 263
EVISTA 111 107 51 128
ROPINIROLE HCL 106 64 52 124
NIFEDIPINE ER 106 84 52 89
LANTUS 105 77 54 51
CLARITHROMYCIN ER 105 79 10 54 367
TRICOR 101 83 56 96
CITALOPRAM HBR 101 88 56 17
PREDNISONE 100 88 58 37
JANUVIA 99 93 59 50
ESCITALOPRAM OXALATE 94 94 60 55
FAMOTIDINE 91 90 61 60
INSULIN SYRINGE 90 73 62 102
LOSARTAN POTASSIUM 90 66 62 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 85 64 42
PAROXETINE HCL 85 58 65 66
AMOX TR-POTASSIUM CLAVULANATE 83 63 66 160
DETROL LA 83 83 66 150
RISPERIDONE 81 81 68 61
SPIRONOLACTONE 78 55 69 65
CIPROFLOXACIN HCL 75 70 70 72
COMBIVENT 75 68 70 144
MECLIZINE HCL 74 73 72 103
CLOTRIMAZOLE-BETAMETHASONE 71 53 73 127
OXYCONTIN 71 32 S2 73 138
LEVOFLOXACIN 70 49 75 106
SINGULAIR 69 62 76 100
NAPROXEN 68 57 77 108
PROPRANOLOL HCL 68 68 77 132
VENLAFAXINE HCL ER 67 67 79 87
DILTIAZEM ER 66 66 80 207
CLONIDINE HCL 65 38 81 70
LIPITOR 61 49 82 78
AMITRIPTYLINE HCL 58 57 R 83 117
MIRTAZAPINE 56 55 84 41
SUCRALFATE 56 55 84 248
IBANDRONATE SODIUM 55 55 86 288
GEMFIBROZIL 54 37 87 133
TAMSULOSIN HCL 53 40 88 29
ACETAMINOPHEN-CODEINE 51 24 S3 89 112
ACTOS 51 32 89 125
NOVOLIN 70-30 50 42 91 268
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.